COVID-19 Vaccines 101: FAQ

Paul Offit, MD, director, Vaccine Education Center, and professor of pediatrics, Children’s Hospital of Philadelphia; professor of vaccinology, Perelman School of Medicine, University of Pennsylvania.

CDC: “Vaccines: The Basics,” “When Vaccine is Limited, Who Gets Vaccinated First?” “Understanding How COVID-19 Vaccines Work,” “Meeting of the Advisory Committee on Immunization Practices (ACIP) November 23,” “Understanding mRNA COVID-19 Vaccines.”

JAMA: “COVID-19 and mRNA Vaccines — First Large Test for a New Approach.”

The Lancet: “Oxford-AstraZeneca COVID-19 vaccine efficacy.”

Facebook interview: Mark Zuckerberg and Anthony Fauci, MD, Nov. 30, 2020.

FDA: “Vaccines and Related Biological Products Advisory Committee Meeting, Dec. 17, 2020.”

Naor Bar-Zeev, PhD, affiliate professor of worldwide well being and vaccinology and deputy director, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore.

Statista.com: “The Cost Per Jab of Covid-19 Vaccine Candidates.”

AstraZeneca: “COVID-19 vaccine AZD1222 is better tolerated in older adults than younger adults with similar immune responses across all age groups.”

The Lancet: “Safety and immunogenicity of ChAdOx1nCoV-19 in a prime-boost regimen in young and old adults (COV002) in a single-blind, randomized, controlled, phase 2/3 trial.”

Moderna: “Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study.”

BMJ.com: “Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows.”

CBS News: “UK warns against giving Pfizer vaccine to people prone to severe allergic reactions.”